Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
After decades of clinical and basic science research, the clinical application of botulinum toxin A (Botox) in urology has been extended to neurogenic detrusor overactivity (NDO), idiopathic detrusor overactivity, refractory overactive bladder (OAB), interstitial cystitis/bladder pain syndrome (IC/B...
Main Authors: | Jing-Liang Chen, Hann-Chorng Kuo |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Urological Association
2020-02-01
|
Series: | Investigative and Clinical Urology |
Subjects: | |
Online Access: | https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-S33.pdf |
Similar Items
-
Adverse Events of Intravesical Onabotulinum Toxin A Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
by: Yuh-Chen Kuo, et al.
Published: (2016-03-01) -
Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction
by: Joseph J. Janicki, et al.
Published: (2016-03-01) -
Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
by: Chun-Hou Liao, et al.
Published: (2015-12-01) -
The application of botulinum toxin in the treatment of overactive bladder
by: Justyna Wojcik, et al.
Published: (2020-09-01) -
Role of liposome in treatment of overactive bladder and interstitial cystitis
by: Shih-Ya Hung, et al.
Published: (2015-03-01)